Marc Gitzinger is the founder of BioVersys. BioVersys has raised $70M in total funding. Latest round: Series C. Backed by GSK. Based in Zurich, Switzerland.
Marc Gitzinger is the Chief Executive Officer and founder of BioVersys, a privately-held clinical stage Swiss pharmaceutical company. BioVersys focuses on the research and development of therapies for life-threatening multidrug-resistant bacterial infections and targeted microbiome modulation. The company announced a CHF 24.2 million Series C financing in June 2022, which was extended by CHF 12.3 million in May 2024, bringing the total Series C to CHF 44.9 million.
Full founder directory · Investor directory · Company funding database · Fundraising library